Anacin

Product NDC: 63736-200
11-digit product format: 637360200
Labeler code: 63736
Product ID: 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
Type: HUMAN OTC DRUG
Nonproprietary name: Asprin and Caffeine
Dosage form: TABLET
Route: ORAL
Labeler: Insight Pharmaceuticals LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2009-06-25
Substance: ASPIRIN; CAFFEINE
Active strength: 400; 32 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded package	package	63736-200	63736-200-04	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-30	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-50	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-91	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-92	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-95	D	Discontinued by firm	2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 64 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-92	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-95	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-91	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-92	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-91	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-95	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-92	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-91	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-95	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-92	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-91	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-95	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-92	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-91	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-95	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-92	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-91	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-95	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-50	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-92	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-04	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-91	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-95	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-92	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-91	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-95	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-04	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-91	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-95	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-04	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-91	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-95	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-91	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-04	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-95	`367a005e9d99…`	`383a685ebd0f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Anacin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	400 mg/1
CAFFEINE	32 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup
3G6A5W338E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198479	Internal RxNorm lookup
211292	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63736-200-04	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-04	Anacin	4 in 1 BLISTER PACK	TABLET	4	9
63736-200-30	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-30	Anacin	30 in 1 BOTTLE	TABLET	30	9
63736-200-50	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-50	Anacin	50 in 1 BOTTLE	TABLET	50	9
63736-200-90	Anacin	100 in 1 BOTTLE	TABLET	100	9
63736-200-90	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-91	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-91	Anacin	130 in 1 BOTTLE	TABLET	130	9
63736-200-92	Anacin	125 in 1 BOX	TABLET	125	9
63736-200-92	Anacin	1 in 1 POUCH	TABLET	1	9
63736-200-93	Anacin	300 in 1 BOTTLE	TABLET	300	9
63736-200-93	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-95	Anacin	750 in 1 BOX	TABLET	750	9
63736-200-95	Anacin	1 in 1 POUCH	TABLET	1	9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Caffeine	ACTIVE INGREDIENT	3G6A5W338E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Aspirin	ACTIVE MOIETY	R16CO5Y76E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Caffeine	ACTIVE MOIETY	3G6A5W338E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63736-200	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS LLC]	8	Current NDC, Legacy NDC, 16 package rows	20250115_51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 33 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EXTRA STRENGTH PAIN RELIEVER	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	Geri-Care Pharmaceutical Corp	b670a898-2360-76e2-e053-2a95a90a3380	2025-11-17	Warnings	Exact identifier application number: M013
Pain Reliever PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	L.N.K. International, Inc.	ec902e52-0f48-4a61-b67d-17e1c1461619	2025-11-15	Warnings	Exact identifier application number: M013
Pain Reliever Extra Strength	ACETAMINOPHEN	L.N.K. International, Inc.	72babe91-2586-4f05-ae90-6debfd23aa5d	2025-11-15	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	Strategic Sourcing Services LLC	3c7883da-6f51-4716-b012-0e33d239a60e	2025-11-15	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	Sam's West Inc	3b84746f-05ab-4f88-b9ae-efb8c5dfc233	2025-11-15	Warnings	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	Walgreen Company	a482e715-bec0-44a4-bb0e-ea5f5fda558e	2025-11-15	Warnings	Exact identifier application number: M013
Acetaminophen PM Extra Strength	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	ARMY AND AIR FORCE EXCHANGE SERVICE	f1157dbc-d86c-4554-954c-60a74674ff6b	2025-11-15	Warnings	Exact identifier application number: M013
Acetaminophen, Aspirin, Caffeine	ACETAMINOPHEN, ASPIRIN, CAFFEINE	NuCare Pharmaceuticals,Inc.	437e4fd9-c7d9-77d6-e063-6294a90a22b7	2025-11-13	Warnings	Exact identifier application number: M013
Good Sense Pain Relief	ACETAMINOPHEN	L. Perrigo Company	7f78028a-484b-48b3-a37a-1e0b055bbefc	2025-11-13	Warnings	Exact identifier application number: M013
OneSsip Acetaminophen	ACETAMINOPHEN	MEDWISE LIFESCIENCES INC.	3f88de0f-6cf6-3580-e063-6294a90abcb4	2025-11-12	Warnings	Exact identifier application number: M013
Tylenol PM Extra Strength	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	Navajo Manufacturing Company Inc.	435b1a31-353d-af20-e063-6294a90aa907	2025-11-11	Warnings	Exact identifier application number: M013
Good Neighbor Pharmacy Pain Relief	ACETAMINOPHEN	Amerisource Bergen	4b829607-f5fb-427f-83b5-5b6b9c44ebeb	2025-11-11	Warnings	Exact identifier application number: M013
Pamprin Max Menstrual Pain Relief	ACETAMINOPHEN AND ASPIRIN AND CAFFEINE	Focus Consumer Healthcare, LLC	5bd4b935-f003-7df8-e053-2a91aa0a5d79	2025-11-10	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN	Shield Pharmaceuticals Corp	61e50135-a7c2-4a86-8a1a-d47b41d3f9d1	2025-11-07	Warnings	Exact identifier application number: M013
Childrens Chewables	ACETAMINOPHEN	Strategic Sourcing Services LLC	af2cbbaf-9b73-440a-bc88-a790cafccc6b	2025-11-07	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	L.N.K. International, Inc.	39e142a7-8590-4e1e-8319-6904fb57cc8a	2025-11-06	Warnings	Exact identifier application number: M013
TYLENOL Extra Strength	ACETAMINOPHEN	Kenvue Brands LLC	42321456-d7dd-3b51-e063-6394a90ac292	2025-11-05	Warnings	Exact identifier application number: M013
Childrens Pain Relief	ACETAMINOPHEN	Family Dollar Services Inc	76058eb3-2d3f-4414-87df-7167cd27d26b	2025-11-05	Warnings	Exact identifier application number: M013
Children Pain and Fever Reliver	ACETAMINOPHEN	Target Corporation	1116f808-f61e-47ec-b0d0-d4be5aa905be	2025-11-04	Warnings	Exact identifier application number: M013
Pain Reliever Dye Free	ACETAMINOPHEN	TIME CAP LABORATORIES, INC.	42c4f0b2-6483-0f3c-e063-6294a90a140f	2025-11-04	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
211292	ANACIN 400 MG / 32 MG Oral Tablet	PSN	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	aspirin 400 MG / caffeine 32 MG Oral Tablet	PSN	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]	SBD	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	aspirin 400 MG / caffeine 32 MG Oral Tablet	SCD	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	ASA 400 MG / Caffeine 32 MG Oral Tablet	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin]	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63736-200-04	63736020004	1 BLISTER PACK in 1 BOX (63736-200-04) > 4 TABLET in 1 BLISTER PACK	1 blister pack	2009-06-25	2023-06-30	No	No	Current
63736-200-30	63736020030	1 BOTTLE in 1 BOX (63736-200-30) > 30 TABLET in 1 BOTTLE	1 bottle	2009-06-25	2023-06-30	No	No	Current
63736-200-50	63736020050	1 BOTTLE in 1 BOX (63736-200-50) > 50 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-90	63736020090	1 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-91	63736020091	1 BOTTLE in 1 BOX (63736-200-91) > 130 TABLET in 1 BOTTLE	1 bottle	2009-06-25	2023-06-30	No	No	Current
63736-200-92	63736020092	125 POUCH in 1 BOX (63736-200-92) > 1 TABLET in 1 POUCH	125 pouch	2009-06-25	0000-00-00	No	No	Current
63736-200-93	63736020093	1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-95	63736020095	750 POUCH in 1 BOX (63736-200-95) > 1 TABLET in 1 POUCH	750 pouch	2009-06-25	2023-06-30	No	No	Current